CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Insiders Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE 00:00:03 24/09/2026 +04			5-day change	1st Jan Change
277.33 ^USD	-2.73%		+1.43%	+39.03%

09-17	Charles River Laboratories International Introduces Rapid Cell Banking Programs with Next-Generation Sequencing Characterization	CI
09-17	Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating	MT

Insiders

08-21	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
08-14	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
08-07	Charles River Laboratories International Insider Sold Shares Worth $1,327,098, According to a Recent SEC Filing	MT
07-02	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
05-12	Charles River Laboratories International, Inc. Announces Board Elections	CI
02-18	Charles River Laboratories International, Inc. Announces Executive Appointments	CI
02-18	Charles River forecasts upbeat 2026 profit on improved demand for drug development services	RE
02-18	Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named	MT
01-13	Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer	MT
01-13	Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer	CI
01-08	Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes	CI
01-08	Charles River Laboratories International, Inc. Announces Changes in Board	CI
01-08	Charles River Laboratories International, Chair, President, CEO James Foster to Retire	MT
01-08	Charles River Laboratories announces planned retirement of James C. Foster	RE
15/10/25	Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption	CI
16/09/25	Charles River Laboratories announces chief financial officer transition	RE
16/09/25	Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025	CI
16/09/25	Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition	CI
16/09/25	Charles River Laboratories Says CFO to Step Down	MT
07/05/25	Charles River to add new directors, review business in agreement with Elliott	RE
07/05/25	Charles River Laboratories International, Inc. Announces Board Changes	CI
13/11/24	Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing	MT
13/08/24	Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing	MT
05/03/24	Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing	MT
02/03/24	Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing	MT